Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: A systematic review

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Zuure, Freke R ^a   Urbanus, Anouk T ^a,b   Langendam, Miranda W ^b   Helsper, Charles W ^c   Van Den Berg, Charlotte H S B ^a,b   Davidovich, Udi ^a   Prins, Maria ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Case detection; Case finding; HCV; Reporting guidelines; Testing

Indexed keywords

AGED; HEPACIVIRUS; HEPATITIS C; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; PREVALENCE; PROCEDURES; PROGRAM EVALUATION; RISK FACTOR;

AGED; HEPACIVIRUS; HEPATITIS C; HUMANS; MASS SCREENING; PREVALENCE; PROGRAM EVALUATION; RISK FACTORS;

EID: 84892651928     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-66     Document Type: Review

References (123)

1. The global burden of hepatitis C. Lavanchy D, Liver Int 2009 29 Suppl 1 74 81
2. Understanding hepatitis C. McHutchison JG, Am J Manag Care 2004 10 21 S29 15084064
3. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. Micallef JM, Kaldor JM, Dore GJ, J Viral Hepat 2006 13 34 41 10.1111/j.1365-2893.2005.00651.x 16364080
4. Natural history of chronic hepatitis C. Seeff LB, Hepatology 2002 36 5 Suppl 1 35 S46 12407575
5. Hepatitis B and C virus infection among 1.2 Million persons with access to care: factors associated with testing and infection prevalence. Spradling PR, Rupp L, Moorman AC, Lu M, Teshale EH, Gordon SC, Nakasato C, Boscarino JA, Henkle EM, Nerenz DR, Denniston MM, Holmberg SD, Clin Infect Dis 2012 55 1047 1055 10.1093/cid/cis616 22875876
6. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS, Public Health Rep 2006 121 710 719 17278406 (Pubitemid 46280261)
7. Public health impact of antiviral therapy for hepatitis C in the United States. Volk ML, Tocco R, Saini S, Lok AS, Hepatology 2009 50 1750 1755 10.1002/hep.23220 19824079
8. Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice. Grishchenko M, Grieve RD, Sweeting MJ, De Angelis D, Thomson BJ, Ryder SD, Irving WL, Int J Technol Assess Health Care 2009 25 171 180 10.1017/S0266462309090229 19331708
9. Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. Siebert U, Sroczynski G, Rossol S, Wasem J, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB, Gut 2003 52 425 432 10.1136/gut.52.3.425 12584228 (Pubitemid 36250066)
10. Future of hepatitis C therapy: development of direct-acting antivirals. Dore GJ, Matthews GV, Rockstroh J, Curr Opin HIV AIDS 2011 6 508 513 10.1097/COH.0b013e32834b87f8 21897228
11. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB, Hepatology 2011 54 1433 1444 10.1002/hep.24641 21898493
12. Screening for Disease in the Community. Friis RH, Sellers TH, Epidemiology for Public Health Practice Canada: Jones and Bartlett Publishers, LLC 4 2009 409 436
13. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention, MMWR 1998 47 No. RR-19 20 26
14. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R, MMWR Recomm Rep 2009 58 1 166
15. Routine practice HCV infection screening with saliva samples: multicentric study in an intravenous drug user population. Lucidarme D, Decoster A, Fremaux D, Harbonnier J, Jacob C, Vosgien V, Josse P, Villeger P, Henrio C, Prouvost-Keller B, Saccardy C, Lemaire M, Vazeille G, Duchene C, Thuillier M, Colbeaux C, Lefebvre AM, Forzy G, Filoche B, Gastroenterol Clin Biol 2007 31 480 484 10.1016/S0399-8320(07)89415-2 17541337 (Pubitemid 46877546)
16. Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. Makris M, Baglin T, Dusheiko G, Giangrande PL, Lee CA, Ludlam CA, Preston FE, Watson HG, Wilde JT, Winter M, Haemophilia 2001 7 339 345 10.1046/j.1365-2516.2001.00527.x 11442636 (Pubitemid 32677650)
17. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Centers for Disease Control and Prevention, MMWR 2009 58 No. RR-4 85 86 (No. RR-4) 19194370
18. Hepatitis C virus prevalence in the Netherlands: migrants account for most infections. Vriend HJ, van Veen MG, Prins M, Urbanus AT, Boot HJ, Op de Coul ELM, Epidemiol Infect 2013 141 6 1310 1317 10.1017/S0950268812001884 22963908
19. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Vrielink H, Reesink HW, van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL, Transfusion 1997 37 845 849 10.1046/j.1537-2995.1997.37897424409.x 9280331 (Pubitemid 27369138)
20. The role of behavioral science theory in development and implementation of public health interventions. Glanz K, Bishop DB, Annu Rev Public Health 2010 31 399 418 10.1146/annurev.publhealth.012809.103604 20070207
21. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Alter HJ, Hepatology 1992 15 350 353 1310478
22. Diagnostic tests for hepatitis C. Gretch DR, Hepatology 1997 26 43S 47S 10.1002/hep.510260708 9305663 (Pubitemid 27388071)
23. Global epidemiology of hepatitis C virus infection. Shepard CW, Finelli L, Alter MJ, Lancet Infect Dis 2005 5 558 567 10.1016/S1473-3099(05)70216-4 16122679 (Pubitemid 41196755)
24. Prevalence of hepatitis C virus infection in pregnant women. Hao F, Zhonghua Fu Chan Ke Za Zhi 1993 28 668 702 8313736
25. A seroepidemiological investigation on HCV infection among population in Tianjin area. Lu C, Zhonghua Liu Xing Bing Xue Za Zhi 1993 14 147 150 8221836
26. Implication of health checkups of students from developing countries in Japan. Fujimoto K, Momosaka Y, Uchida K, Ide H, Narisada H, Fujishiro K, Oda S, Okubo T, Nippon Koshu Eisei Zasshi 1999 46 476 486 10513090
27. Natural history of HCV seropositive cases found in health screening. Fukui M, Hokkaido Igaku Zasshi 1995 70 69 82 7538093
28. Present status of community-based HCV screening in Ikeda-Toyono Region, Osaka Prefecture, 2002. Imai Y, Tanaka H, Fukudai K, Zushi S, Yabuta T, Tujino A, Kurokawa M, Kono Y, Nishi K, Hayashi M, Acta Hepatologica Japonica 2004 45 232 238 10.2957/kanzo.45.232 (Pubitemid 38855672)
29. Economic evaluation of health care program for hepatitis C virus antibody screening. Ishizuka M, Nippon Koshu Eisei Zasshi 1999 46 447 465 10513088
30. Epidemiologic aspects of cases with positive HCV antibody and clinical features of hepatocellular carcinoma with positive HCV antibody based on mass survey in a rural area of Chiba prefecture. Kajikawa T, Katahira Y, Ohto M, Hara K, Umezono T, Saito M, Yoshikawa M, Sugiura N, Ebara M, Saisho H, Acta Hepatologica Japonica 1996 37 13 18 10.2957/kanzo.37.13 (Pubitemid 26067674)
31. The screening of hepatitis virus and its efficacy. Kuroki T, Murai J, Fujino K, Ozaki S, Nakagishi M, Toukaiya M, Rinsho Byori 1995 43 1095 1100 8551671
32. An epidemiological study of hepatitis C virus infection in a local district in Japan. Michitaka K, Horiike N, Ohta Y, Rinsho Byori 1991 39 586 591 1908912
33. Survey for hepatitis in an isolated endemic area. Watanabe Y, Machida K, Sato A, Ota S, Kiyosawa K, Nippon Koshu Eisei Zasshi 1996 43 989 996 9033214
34. Viral hepatitis B and C among immigrants in Iceland. Jonsdottir G, Briem H, Blondal T, Palsson G, Olafsson S, Gudnason T, Laeknabladid 2006 92 669 673 17062900
35. Screening of hepatitis markers for viral hepatitis B and C in healthy persons in the region of Stara Zagora. Djeneva H, Aleksieva T, Bulg Med 2003 11 6 8 (Pubitemid 38249755)
36. Analysis of some viral infections, transmitted by parenteral and sexual routes, in the Republic of Azerbaijan. Galetskii SA, Seniuta NB, Syrtsev AV, Abdullaev OM, Aliev DA, Kerimov AA, Yamashita M, Hayami M, Kato T, Mizokami M, Vopr Virusol 1999 44 232 236 10544453 (Pubitemid 129741049)
37. Frequency of encountering markers of viral hepatitis A, B, and C in the aboriginal inhabitants of the northwest region of Siberia. Netesova IG, Iaroslavtseva OA, Dryga SA, Posukh OL, Osipova LP, Bronshtein EL, Zaitsev SA, Netesov SV, Vopr Virusol 1995 40 172 174 7483569
38. Infections caused by hepatitis virus B and C at inhabitants of Baku. Tagizadeh RK, Mammadov MK, Dadashova AE, Azimova AA, Azerbaijan Med J 2008 1 131 134 (Pubitemid 351395569)
39. Prevalence of hepatitis B and C in first grade primary school children living in Sivas, Turkey. Ayvaz A, Nur N, Engin A, Cetinkaya S, Turk Pediatri Arsivi 2010 45 132 136
40. Prevalence of hepatitis C virus antibodies in hospital personnel. Cagatay M, Tulek N, Koksalan H, Mert A, Mikrobiyol Bul 1992 26 242 247 1382216
41. Hepatitis C antibodies in health personnel. Pazdiora P, Topolcan O, Herynkova R, Cesk Epidemiol Mikrobiol Imunol 1994 43 29 31 7513266
42. Community-based hepatocellular carcinoma screening in seven townships in Taiwan. Chen CJ, Lu SN, You SL, Wu MH, Wang LY, Lee LT, Huang GT, Yang PM, Lee HS, J Formos Med Assoc 1995 94 Suppl 2 94 102 8672950
43. Screening of chronic active hepatitis from series of health examination database. Tung W-C, Lu S-N, Wu M-H, Chen C-J, J Intern Med Taiwan 2004 15 65 75 (Pubitemid 38779767)
44. Development of prevention programmes for HIV, hepatitis and sexually transmitted infections among migrants consulting in the doctors of the World French centers. Pauti MD, Simonnot N, Estecahandy P, Med Mal Infect 2008 38 495 499 10.1016/j.medmal.2008.06.028 18706782
45. Development of actions for the prevention of HIV, hepatitis and Sexually Transmitted Infections among immigrants consulting in the Doctors of the World "Missions France" Pauti MD, Simonnot N, Estecahandy P, Med Mal Infect 2009 39 191 195 10.1016/j.medmal.2008.12.004 19272722
46. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. Uddin G, Shoeb D, Solaiman S, Marley R, Gore C, Ramsay M, Harris R, Ushiro-Lumb I, Moreea S, Alam S, Thomas HC, Khan S, Watt B, Pugh RN, Ramaiah S, Jervis R, Hughes A, Singhal S, Cameron S, Carman WF, Foster GR, J Viral Hepat 2010 17 327 335 10.1111/j.1365-2893.2009.01240.x 20002307
47. Vietnamese community screening for hepatitis B virus and hepatitis C virus. Kallman JB, Tran S, Arsalla A, Haddad D, Stepanova M, Fang Y, Wrobel VJ, Srishord M, Younossi ZM, J Viral Hepat 2011 18 1 70 76 10.1111/j.1365-2893.2010. 01278.x 20196807
48. Viral hepatitis in a homeless shelter in Hawai'i. Boyce DE, Tice AD, Ona FV, Akinaka KT, Lusk H, Hawaii Med J 2009 68 113 115 19583106
49. Blood exposures and hepatitis C virus infections among emergency responders. Datta SD, Armstrong GL, Roome AJ, Alter MJ, Arch Intern Med 2003 163 2605 2610 10.1001/archinte.163.21.2605 14638560 (Pubitemid 37464418)
50. Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening. Hwang JP, Mohseni M, Gor BJ, Wen S, Guerrero H, Vierling JM, Am J Public Health 2010 100 Suppl 1 118 S124 20147697
51. Anti-HCV in patients transfused, in a health area attended by a family physician. Medical Office 19 de Abril. Jimenez FP, Fuentes HM, Borbolla BE, Acta Gastroenterol Latinoam 2000 30 99 105 10925726
52. Improving hepatitis C services across the UK: response to a walk-in HCV testing service. D'Souza RF, Glynn MJ, Alstead E, Foster GR, Ushiro-Lumb I, Gut 2004 53 1388 (Pubitemid 39120134)
53. Benefits and adverse effects of hepatitis C screening: early results of a screening program. Trepka MJ, Zhang G, Leguen F, Obiaja K, Malow RM, De La Rosa M, J Public Health Manag Pract 2007 13 263 269 10.1097/01.PHH.0000267684.23529. 2c 17435493 (Pubitemid 46624964)
54. Anonymous and free screenings: population comparison between those conducted on-site in a testing centre and those done off-site. Plard C, Shelly M, Millot J, Segouin C, Bertrand D, Le Divenah A, Sante Publique 2007 19 355 362 10.3917/spub.075.0355 18064838
55. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Meky FA, Stoszek SK, Abdel-Hamid M, Selim S, Abdel-Wahab A, Mikhail N, El-Kafrawy S, El-Daly M, Abdel-Aziz F, Sharaf S, Mohamed MK, Engle RE, Emerson SU, Purcell RH, Fix AD, Strickland GT, Clin Infect Dis 2006 42 628 633 10.1086/500133 16447107 (Pubitemid 43271375)
56. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Lu SN, Chen HC, Tang CM, Wu MH, Yu ML, Chuang WL, Lu CF, Chang WY, Chen CJ, Pediatr Infect Dis J 1998 17 142 145 10.1097/00006454- 199802000-00012 9493811 (Pubitemid 28096013)
57. Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. Aslam M, Aslam J, J Clin Gastroenterol 2001 33 407 411 10.1097/00004836-200111000-00013 11606859 (Pubitemid 33026728)
58. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC, J Formos Med Assoc 2007 106 148 155 10.1016/S0929-6646(09)60231-X 17339159
59. Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services' sexually transmitted disease clinics. D'Souza G, Arafat R, Hwang L, Cunningham C, Shah S, Reynolds K, J Viral Hepat 2003 10 134 140 10.1046/j.1365-2893.2003.00410.x 12614470 (Pubitemid 36359851)
60. Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. Scott C, Day S, Low E, Sullivan A, Atkins M, Asboe D, J Infect 2010 60 351 353 10.1016/j.jinf.2010.01.013 20153770
61. Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida. Weisbord JS, Trepka MJ, Zhang G, Smith IP, Brewer T, Sex Transm Infect 2003 79 1 10.1136/sti.79.1.e1 12576631
62. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS, Sex Transm Dis 2003 30 340 344 10.1097/00007435-200304000-00013 12671556 (Pubitemid 36397837)
63. Screening for hepatitis C in sexual health clinic attendees. Mapagu MC, Martin SJ, Currie MJ, Bowden FJ, Sex Health 2008 5 73 76 10.1071/SH07034 18361858 (Pubitemid 351301113)
64. Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. Zimmerman R, Finley C, Rabins C, McMahon K, Public Health Rep 2007 122 Suppl 2 18 23 17542448 (Pubitemid 47443826)
65. Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Subiadur J, Harris JL, Rietmeijer CA, Public Health Rep 2007 122 Suppl 2 12 17 17542447 (Pubitemid 47443825)
66. Texas statewide hepatitis C counseling and testing, 2000-2005. Heseltine G, McFarlane J, Public Health Rep 2007 122 Suppl 2 6 11 17542446 (Pubitemid 47443824)
67. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS, Sex Transm Dis 2001 28 166 170 10.1097/00007435-200103000-00008 11289199 (Pubitemid 32194972)
68. Hepatitis C testing should be performed routinely in all patients attending sexual health services. Abstract for the 2nd Joint Conference of the British HIV Association and the British Association for Sexual Health and HIV Manchester United Kingdom. Ellks R, HIV Med 2010 59
69. Hepatitis C testing in sexual health services in England, 2002-7: results from sentinel surveillance. Tweed E, Brant L, Hurrelle M, Klapper P, Ramsay M, Sex Transm Infect 2010 86 126 130 10.1136/sti.2009.036590 19858534
70. Organized hepatitis C screening. Results and cost of a one-year campaign in a pilot area. Monnet E, Mercet P, Woronoff-Lemsi MC, Bresson-Hadni S, Pruniaux J, Cottray P, Bouiller C, Allemand H, Miguet JP, Gastroenterol Clin Biol 2000 24 541 546 10891743 (Pubitemid 30489382)
71. Evaluation of a general practice based hepatitis C virus screening intervention. Anderson EM, Mandeville RP, Hutchinson SJ, Cameron SO, Mills PR, Fox R, Ahmed S, Taylor A, Spence E, Goldberg DJ, Scott Med J 2009 54 3 7
72. Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district. Ouzan D, Cavailler P, Hofliger P, Mamino C, Joly H, Tran A, Gastroenterol Clin Biol 2003 27 376 380 12759676 (Pubitemid 36987535)
73. Efficiency of hepatitis C virus screening strategies in general practice. Josset V, Torre JP, Tavolacci MP, Van Rossem-Magnani V, Anselme K, Merle V, Godart J, Libert A, Ladner J, Czernichow P, Gastroenterol Clin Biol 2004 28 351 357 10.1016/S0399-8320(04)94935-4 15146150 (Pubitemid 38691089)
74. Prevalence of hepatitis C infection among general practice patients in the Lyon area, France. Pradat P, Caillat-Vallet E, Sahajian F, Bailly F, Excler G, Sepetjan M, Trepo C, Fabry J, Eur J Epidemiol 2001 17 47 51 10.1023/A:1010902614443 11523575 (Pubitemid 32756591)
75. Screening of patients at risk for hepatitis C virus infection in general medicine. Altman C, Lesiour A, Dunbavand A, Meyer L, de la Selle P, Buffet C, Gastroenterol Clin Biol 1999 23 359 362 10384340 (Pubitemid 29262422)
76. A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign. Helsper CW, van Essen GA, Bonten MJ, de Wit NJ, Fam Pract 2010 27 328 332 10.1093/fampra/cmq006 20223833
77. Hepatitis C screening practices among private practitioners: impact of an information campaign. Sahajian F, Excler G, Bailly F, Caillat-Vallet E, Trepo C, Sepetjan M, Fabry JY, Gastroenterol Clin Biol 2004 28 714 719 10.1016/S0399-8320(04)95061-0 15646538 (Pubitemid 39318161)
78. Strategies of hepatitis C screening in general practice. Results of a two-center randomized trial. Roudot-Thoraval F, Monnet E, Mercet P, Bastie A, Dhumeaux D, Miguet JP, Gastroenterol Clin Biol 2000 24 1037 1041 11139672 (Pubitemid 32002945)
79. Outcomes of a Hepatitis C screening program at a large urban VA medical center. Groom H, Dieperink E, Nelson DB, Garrard J, Johnson JR, Ewing SL, Stockley H, Durfee J, Jonk Y, Willenbring ML, Ho SB, J Clin Gastroenterol 2008 42 97 106 10.1097/MCG.0b013e31802dc56f 18097298
80. Outcome of screening for hepatitis C virus infection based on risk factors. Mallette C, Flynn MA, Promrat K, Am J Gastroenterol 2008 103 131 137 10.1111/j.1572-0241.2007.01522.x 17894850
81. Effectiveness of a screening program for hepatitis C. Cheung RC, Cunningham BA, Cooper AD, Dig Dis Sci 2006 51 976 981 10.1007/s10620-006-9100-x 16642419 (Pubitemid 44030825)
82. Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders. Rifai MA, Moles JK, Lehman LP, Van der Linden BJ, Psychosomatics 2006 47 112 121 10.1176/appi.psy.47.2.112 16508022 (Pubitemid 43346958)
83. Analysis of a hepatitis C screening programme for US veterans. Zuniga IA, Chen JJ, Lane DS, Allmer J, Jimenez-Lucho VE, Epidemiol Infect 2006 134 249 257 16490127 (Pubitemid 43280231)
84. Observational outcomes in a cohort of women identified as hepatitis C (HCV) antibody positive during routine antenatal clinic (ANC) screening. Abstract for the 60th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2009 Boston, MA United States. Alexanian AA, Oleszkiewicz GM, Al-Chalabi T, Atabani S, Muir D, Tudor-Williams G, Brown AS, Hepatology 2009 669A
85. Viral screening and assisted conception treatment-the Bourn Hall experience. Abusheikha N, Akagbosu F, Marcus S, Lass A, Cousins C, Brinsden P, J Assist Reprod Genet 1999 16 337 339 10.1023/A:1020414318129 10394532 (Pubitemid 29314353)
86. Epidemiologic predictors of hepatitis C virus infection in pregnant women. Leikin EL, Reinus JF, Schmell E, Tejani N, Obstet Gynecol 1994 84 529 534 7522312 (Pubitemid 24311143)
87. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Ward C, Tudor-Williams G, Cotzias T, Hargreaves S, Regan L, Foster GR, Gut 2000 47 277 280 10.1136/gut.47.2.277 10896922 (Pubitemid 30489774)
88. Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. Costa ZB, Machado GC, Avelino MM, Gomes FC, Macedo Filho JV, Minuzzi AL, Turchi MD, Stefani MM, de Souza WV, Martelli CM, BMC Infect Dis 2009 9 116 10.1186/1471-2334-9-116 19635135
89. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort. Freudenreich O, Gandhi RT, Walsh JP, Henderson DC, Goff DC, Psychosomatics 2007 48 405 411 10.1176/appi.psy.48.5.405 17878499 (Pubitemid 47330293)
90. Prevalence of hepatitis C in two inpatient psychiatry populations. Gunewardene R, Lampe L, Ilchef R, Australas Psychiatry 2010 18 330 334 10.3109/10398561003763273 20645899
91. Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours. Lacey C, Ellen S, Devlin H, Wright E, Mijch A, Australas Psychiatry 2007 15 315 319 10.1080/10398560701358113 17612885 (Pubitemid 47073037)
92. Hepatitis C virus infection risk factors in patients admitted in hospital emergency departments in Picardy. Value of oriented screening based on recommendations of the 'Direction Generale de la Sante'. Capron D, Bensousan T, Darchis JP, Barbare JC, Butel J, Bental A, Cadranel JF, Goll A, Levy P, Ink O, Autret P, Bouraya D, Thiebaut JM, Moucheron JJ, Bernard M, Lallement PY, Delobel P, Eur J Gastroenterol Hepatol 1999 11 643 648 10.1097/00042737-199906000-00010 10418936 (Pubitemid 29348982)
93. Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening programme on the basis of their prevalence and transmission risk factors? Alswaidi FM, O'Brien SS, J Epidemiol Community Health 2009
94. Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup. Dubois F, Francois M, Mariotte N, Caces E, Vol S, Roingeard P, Barin F, Goudeau A, Tichet J, J Hepatol 1994 21 837 841 10.1016/S0168-8278(94)80247-5 7890901 (Pubitemid 24374152)
95. Improved but still suboptimal uptake of STI testing and vaccination in the outreach setting. Abstract for the 2nd Joint Conference of the British HIV Association and the British Association for Sexual Health and HIV Manchester United Kingdom. Roberts J, Cull M, Dean G, Richardson D, Fisher M, HIV Med 2010 118
96. Prevalence of hepatitis C virus infection among men who have sex with men at a Boston community health center and its association with markers of high-risk behavior. Cohen DE, Russell CJ, Golub SA, Mayer KH, AIDS Patient Care STDS 2006 20 557 564 10.1089/apc.2006.20.557 16893325 (Pubitemid 44769203)
97. Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Campello C, Poli A, Dal MG, Besozzi-Valentini F, Infection 2002 30 7 12 10.1007/s15010-001-1197-4 11876521 (Pubitemid 34146405)
98. Prevalence of Hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. Tafuri S, Prato R, Martinelli D, Melpignano L, De Palma M, Quarto M, Germinario C, BMC Infect Dis 2010 10 213 10.1186/1471-2334-10-213 20646306
99. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France. Sahajian F, Vanhems P, Bailly F, Fabry J, Trepo C, Sepetjan M, Eur J Public Health 2007 17 263 271 10.1093/eurpub/ ckl233 17068003 (Pubitemid 47356290)
100. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ, Arch Intern Med 2009 169 364 371 10.1001/archinternmed.2008.564 19237720
101. Implementation Intentions: Strong effects of simple plans. Gollwitzer PM, Am Psychol 1999 54 493 503
102. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention, MMWR 2003 52 (No. RR-3)
103. Hepatitis C screenings available at FNDC. Grimaudo NJ, Lado E, Todays FDA 2000 12 28 30 11404974
104. H.A.L.T. hepatitis C in Tennessee. Wadley F, Tenn Med 1997 90 395 9323903
105. Cost-effectiveness of the national screening program for hepatitis C virus in the general population and the high-risk groups. Nakamura J, Terajima K, Aoyagi Y, Akazawa K, Tohoku J Exp Med 2008 215 33 42 10.1620/tjem.215.33 18509233 (Pubitemid 351791266)
106. Cost-effectiveness and population outcomes of general population screening for hepatitis C. Coffin PO, Scott JD, Golden MR, Sullivan SD, Clin Infect Dis 2012 54 1259 1271 10.1093/cid/cis011 22412061
107. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM, Ann Intern Med 2012 156 263 270 10.7326/0003-4819-156-4-201202210-00378 22056542
108. Principles and practice of mass screening for disease. Wilson JM, Jungner YG, Bol Oficina Sanit Panam 1968 65 281 393 4234760
109. Jones L, Bates G, McCoy E, Beynon C, McVeigh J, Bellis M, A Systematic Review of the Effectiveness and Cost-Effectiveness of Interventions Aimed at Raising Awareness and Engaging with Groups who are at an Increased Risk of Hepatitis B and C Infection-Final Report Liverpool: Liverpool John Moores University Centre for Public Health, Faculty of Health and Applied Social Sciences. 2012
110. Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW, Ann Intern Med 2012 157 817 822 10.7326/0003-4819-157-9-201211060-00529 22910836
111. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Kawakami Y, Akazawa K, Kashiwagi S, Am J Gastroenterol 1995 90 794 799 7537445
112. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group. Kaur S, Rybicki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD, Hepatology 1996 24 979 986 8903363 (Pubitemid 26365891)
113. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G, Hepatology 1994 20 1442 1449 10.1002/hep.1840200611 7982643 (Pubitemid 24359054)
114. Detection of the hepatitis C virus in a population of adults. Fagundes GD, Bonazza V, Ceretta LB, Back AJ, Bettiol J, Rev Lat Am Enfermagem 2008 16 396 400 18695812
115. High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York City metropolitan area: results of a community-based screening program. Batash S, Khaykis I, Raicht RF, Bini EJ, Am J Gastroenterol 2008 103 922 927 10.1111/j.1572-0241.2008.01789.x 18397420 (Pubitemid 351501117)
116. Intérêt d'un "parcours santé" proposé aux résidents d'un foyer Sonacotra. ARèS 92, BEH 2004 43 205 206
117. Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Goetz AM, Ndimbie OK, Wagener MM, Muder RR, Transplant 1995 59 990 994 10.1097/00007890-199504150-00012
118. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC, Arch Intern Med 1993 153 1705 1712 10.1001/archinte.1993. 00410140095011 8333808 (Pubitemid 23217877)
119. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. Panlilio AL, Shapiro CN, Schable CA, Mendelson MH, Montecalvo MA, Kunches LM, Perry SW 3rd, Edwards JR, Srivastava PU, Culver DH, J Am Coll Surg 1995 180 16 24 8000651
120. Hepatitis C screening and prevalence among urban public safety workers. Upfal MJ, Naylor P, Mutchnick MM, J Occup Environ Med 2001 43 402 411 10.1097/00043764-200104000-00019 11322101 (Pubitemid 32378078)
121. Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Gershon RR, Vlahov D, Farzadegan H, Alter MJ, Infect Control Hosp Epidemiol 1995 16 194 197 10.2307/30140977 7636165
122. Vaccination and screening of medical students: results of a student health initiative. Torda AJ, Med J Aust 2008 189 484 486 18976187
123. Value of targeting at-risk populations at outreach venues: Findings from a local sauna. Arumainayagam J, Grimshaw R, Acharya S, Chandramani S, Morrall IA, Pugh RN, Int J STD AIDS 2009 20 642 643 10.1258/ijsa.2008.008424 19710339